JP2002506648A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002506648A5 JP2002506648A5 JP2000536863A JP2000536863A JP2002506648A5 JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5 JP 2000536863 A JP2000536863 A JP 2000536863A JP 2000536863 A JP2000536863 A JP 2000536863A JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- composition according
- vaccination
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK36498 | 1998-03-16 | ||
| DK0364/98 | 1998-03-16 | ||
| PCT/DK1999/000136 WO1999047680A1 (en) | 1998-03-16 | 1999-03-16 | Mutant recombinant allergens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002506648A JP2002506648A (ja) | 2002-03-05 |
| JP2002506648A5 true JP2002506648A5 (enExample) | 2006-05-11 |
Family
ID=8092687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000536863A Pending JP2002506648A (ja) | 1998-03-16 | 1999-03-16 | 突然変異体組換えアレルゲン |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040091500A1 (enExample) |
| EP (1) | EP1062341B1 (enExample) |
| JP (1) | JP2002506648A (enExample) |
| KR (1) | KR20010041918A (enExample) |
| CN (1) | CN1332029C (enExample) |
| AT (1) | ATE408690T1 (enExample) |
| AU (1) | AU749749B2 (enExample) |
| CA (1) | CA2323687C (enExample) |
| DE (1) | DE69939584D1 (enExample) |
| DK (1) | DK1062341T3 (enExample) |
| ES (1) | ES2313776T3 (enExample) |
| HU (1) | HUP0101464A3 (enExample) |
| IL (2) | IL138339A0 (enExample) |
| NO (1) | NO328354B1 (enExample) |
| NZ (1) | NZ506665A (enExample) |
| PL (1) | PL194804B1 (enExample) |
| PT (1) | PT1062341E (enExample) |
| WO (1) | WO1999047680A1 (enExample) |
| ZA (1) | ZA200004819B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226770B2 (en) * | 2000-04-28 | 2007-06-05 | Novozymes A/S | Lipolytic enzyme variant |
| IT1318690B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti dell'allergene maggiore par j 2 di parietaria judaica. |
| IT1318692B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti di proteine allergeniche di phleum pratense. |
| ATE403152T1 (de) * | 2000-10-17 | 2008-08-15 | Besst Test Aps | Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe |
| PL214225B1 (pl) * | 2000-11-16 | 2013-07-31 | Alk Abello As | Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja farmaceutyczna, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sekwencja DNA kodujaca zrekombinowany alergen, wektor ekspresyjny, komórka gospodarza oraz sposób produkcji zrekombinowanego zmutowanego alergenu |
| DK1219300T3 (da) * | 2000-12-28 | 2007-03-05 | Biomay Prod & Handel | Behandling af allergi |
| EP1499349B1 (en) * | 2001-03-02 | 2009-11-18 | The Rockefeller University | Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| WO2003031981A2 (en) * | 2001-10-05 | 2003-04-17 | Novozymes A/S | Kit for predicting binding of a specific antibody to a potential immunogen and method of screening |
| PT1478662E (pt) * | 2002-02-27 | 2009-12-29 | Merck Patent Gmbh | Método para o fabrico do alergeno principal do pólen de bétula hipoalergénico rbet v 1 |
| EP1504089A2 (en) * | 2002-05-16 | 2005-02-09 | Alk Abell A/S | Allergen mutants |
| JP2006520184A (ja) * | 2002-11-01 | 2006-09-07 | アルカベロ アクチェセルスカプ | 組換えタンパク質変種 |
| WO2004047793A1 (en) | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| EP2272502A1 (en) | 2003-12-19 | 2011-01-12 | Alk-Abelló A/S | Cryogranules of a liquid composition of an allergen product |
| EP2324850A1 (en) | 2005-10-04 | 2011-05-25 | Alk-Abelló A/S | Solid vaccine formulation |
| ITMI20052517A1 (it) * | 2005-12-29 | 2007-06-30 | Lofarma Spa | Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa |
| JP2009534029A (ja) * | 2006-04-20 | 2009-09-24 | ナショナル ユニバーシティ オブ シンガポール | 組換え乳酸桿菌およびその使用 |
| CN101657213B (zh) * | 2007-02-15 | 2014-02-26 | 曼康公司 | 用于增强t细胞应答的方法 |
| EP1974746B1 (en) | 2007-03-28 | 2012-01-11 | Alk-Abelló A/S | Use of an adjuvanted allergy vaccine formulation for parenteral administration |
| EP2028188A1 (en) * | 2007-08-21 | 2009-02-25 | Biomay AG | Hypoallergenic molecules |
| DE202008006598U1 (de) | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
| WO2010146171A1 (en) | 2009-06-19 | 2010-12-23 | Alk-Abelló A/S | Novel manner of administering allergen in allergen specific immunotherapy |
| CN102584966A (zh) * | 2011-11-14 | 2012-07-18 | 广州医学院第二附属医院 | 一种重组花生过敏原与突变体及其制备方法和应用 |
| CN102690340A (zh) * | 2012-03-30 | 2012-09-26 | 广州医学院第二附属医院 | 一种重组巴西坚果过敏原与突变体及其制备方法和应用 |
| CN102617719A (zh) * | 2012-03-30 | 2012-08-01 | 广州医学院第二附属医院 | 一种重组大米过敏原与突变体及其制备方法和应用 |
| CN102603879A (zh) * | 2012-03-30 | 2012-07-25 | 广州医学院第二附属医院 | 一种重组大豆过敏原与突变体及其制备方法和应用 |
| CN102617715A (zh) * | 2012-03-30 | 2012-08-01 | 广州医学院第二附属医院 | 一种重组真菌主要过敏原与突变体及其制备方法和应用 |
| CN102675439A (zh) * | 2012-03-31 | 2012-09-19 | 广州医学院第二附属医院 | 一种重组黑麦草花粉过敏原与突变体的制备方法和应用 |
| EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
| EP4058059B1 (en) * | 2019-11-13 | 2024-10-09 | The Regents Of The University Of Michigan | Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation |
| CN111187606B (zh) * | 2020-02-25 | 2022-06-14 | 江苏海洋大学 | 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804201A (en) * | 1996-03-11 | 1998-09-08 | The Rockefeller University | Immunomodulatory peptides of vespid antigen 5 |
| CA2319437C (en) * | 1998-01-31 | 2009-06-16 | University Of Arkansas | Methods and reagents for decreasing allergic reactions |
| IT1318692B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti di proteine allergeniche di phleum pratense. |
-
1999
- 1999-03-16 AU AU27147/99A patent/AU749749B2/en not_active Ceased
- 1999-03-16 EP EP99907345A patent/EP1062341B1/en not_active Revoked
- 1999-03-16 JP JP2000536863A patent/JP2002506648A/ja active Pending
- 1999-03-16 HU HU0101464A patent/HUP0101464A3/hu unknown
- 1999-03-16 PL PL343029A patent/PL194804B1/pl not_active IP Right Cessation
- 1999-03-16 IL IL13833999A patent/IL138339A0/xx unknown
- 1999-03-16 DK DK99907345T patent/DK1062341T3/da active
- 1999-03-16 CN CNB998040312A patent/CN1332029C/zh not_active Expired - Fee Related
- 1999-03-16 WO PCT/DK1999/000136 patent/WO1999047680A1/en not_active Ceased
- 1999-03-16 CA CA002323687A patent/CA2323687C/en not_active Expired - Fee Related
- 1999-03-16 KR KR1020007010225A patent/KR20010041918A/ko not_active Ceased
- 1999-03-16 AT AT99907345T patent/ATE408690T1/de active
- 1999-03-16 PT PT99907345T patent/PT1062341E/pt unknown
- 1999-03-16 NZ NZ506665A patent/NZ506665A/en not_active IP Right Cessation
- 1999-03-16 ES ES99907345T patent/ES2313776T3/es not_active Expired - Lifetime
- 1999-03-16 DE DE69939584T patent/DE69939584D1/de not_active Expired - Lifetime
-
2000
- 2000-09-07 IL IL138339A patent/IL138339A/en not_active IP Right Cessation
- 2000-09-12 ZA ZA200004819A patent/ZA200004819B/xx unknown
- 2000-09-15 NO NO20004614A patent/NO328354B1/no not_active IP Right Cessation
-
2003
- 2003-11-20 US US10/719,553 patent/US20040091500A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004523498A5 (enExample) | ||
| JP2004529078A5 (enExample) | ||
| JP2004532810A5 (enExample) | ||
| JP2004515500A5 (enExample) | ||
| ZA200300712B (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome. | |
| JP2001521739A5 (enExample) | ||
| CA2380072A1 (en) | Nicotine in therapeutic angiogenesis and vasculogenesis | |
| JP2003520232A5 (enExample) | ||
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| JP2001131087A5 (enExample) | ||
| JP2000503980A5 (enExample) | ||
| DK1399133T4 (da) | Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf | |
| JP2002523184A5 (enExample) | ||
| ATE485833T1 (de) | Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern | |
| JP2000141643A5 (enExample) | ||
| JP2004500380A5 (enExample) | ||
| DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| JP2002509169A5 (enExample) | ||
| NO20032597D0 (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
| JP2002114686A5 (enExample) | ||
| SE0001916D0 (sv) | Novel formulation | |
| JP2000095900A5 (enExample) | ||
| JPH10237071A5 (enExample) | ||
| JP2002275230A5 (enExample) | ||
| JP2002531135A5 (enExample) |